Fig. 4
From: Achievement of pathological complete response with osimertinib for EGFR-mutated lung adenocarcinoma
Computed tomography and positron emission tomography after osimertinib treatment. Computed tomography after 4 months’ osimertinib treatment (coronal section [left] and transverse section [right upper]) showed a marked tumor shrinkage. No apparent tumor invasion into the left antrum was observed. Positron emission tomography revealed no significant glucose uptake with the maximum standardized uptake value of 1.7 (right lower)